非小细胞肺癌FDG摄取非球度在多中心研究中的可重复性与协调化
该回顾性研究纳入50例非小细胞肺癌患者,评估不同重建算法和采集时间对原发肿瘤代谢体积非球度(ASP)可重复性的影响。结果显示ASP差异主要取决于重建空间分辨率,多中心研究应追求可比的全宽半高(FWHM,如7 mm),可将ASP分类不一致病例比例降至可接受水平(TOF和PSF+TOF<5%,Q.Clear 10%)。
要点
- 重建空间分辨率是ASP差异的主要决定因素。
- 多中心研究应统一FWHM至约7 mm以减少不一致。
- 分辨率更优的数据可回顾性平滑至目标FWHM。
核心结论
- ASP差异主要取决于重建空间分辨率,多中心研究应追求可比的FWHM(如7 mm)。
研究设计与样本
- 回顾性研究纳入50例非小细胞肺癌患者,行治疗前FDG-PET/CT,评估不同重建算法和采集时间下ASP的可重复性。
主要发现
- 在7 mm FWHM比较时,ASP差异最低,不一致病例比例(ASP>19.5% vs ≤19.5%)最低(TOF4/8 2%,PSF+TOF2/17 4%,Q.Clear 10%)。
- 将5 mm FWHM数据平滑至7 mm FWHM可显著减少不一致病例(TOF4/8从38%降至2%,PSF+TOF2/17从12%降至4%,Q.Clear从10%降至6%)。
- 采集时间短于90秒仅增加不一致病例比例。
关键数值与推荐
- ASP分类阈值:>19.5% vs ≤19.5%。
- 推荐多中心研究追求可比FWHM(如7 mm,由平面滤波器宽度决定),可使TOF和PSF+TOF不一致比例<5%,Q.Clear为10%。
临床怎么用
- 在多中心研究中,应统一重建空间分辨率至约7 mm FWHM以提高ASP可比性。
- 对于分辨率更优的数据,可回顾性平滑至目标FWHM以减少不一致病例。
- 采集时间不宜短于90秒以避免增加ASP分类不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Asphericity (ASP) of the primary tumor's metabolic tumor volume (MTV) in FDG-PET/CT is independently predictive for survival in patients with non-small cell lung cancer (NSCLC). However, comparability between PET systems may be limited. Therefore, reproducibility of ASP was evaluated at varying image reconstruction and acquisition times to assess feasibility of ASP assessment in multicenter studies. METHODS: This is a retrospective study of 50 patients with NSCLC (female 20; median age 69 years) undergoing pretherapeutic FDG-PET/CT (median 3.7 MBq/kg; 180 s/bed position). Reconstruction used OSEM with TOF4/16 (iterations 4; subsets 16; in-plane filter 2.0, 6.4 or 9.5 mm), TOF4/8 (4 it; 8 ss; filter 2.0/6.0/9.5 mm), PSF + TOF2/17 (2 it; 17 ss; filter 2.0/7.0/10.0 mm) or Bayesian-penalized likelihood (Q.Clear; beta, 600/1750/4000). Resulting reconstructed spatial resolution (FWHM) was determined from hot sphere inserts of a NEMA IEC phantom. Data with approx. 5-mm FWHM were retrospectively smoothed to achieve 7-mm FWHM. List mode data were rebinned for acquisition times of 120/90/60 s. Threshold-based delineation of primary tumor MTV was followed by evaluation of relative ASP/SUVmax/MTV differences between datasets and resulting proportions of discordantly classified cases. RESULTS: Reconstructed resolution for narrow/medium/wide in-plane filter (or low/medium/high beta) was approx. 5/7/9 mm FWHM. Comparing different pairs of reconstructed resolution between TOF4/8, PSF + TOF2/17, Q.Clear and the reference algorithm TOF4/16, ASP differences was lowest at FWHM of 7 versus 7 mm. Proportions of discordant cases (ASP > 19.5% vs. ≤ 19.5%) were also lowest at 7 mm (TOF4/8, 2%; PSF + TOF2/17, 4%; Q.Clear, 10%). Smoothing of 5-mm data to 7-mm FWHM significantly reduced discordant cases (TOF4/8, 38% reduced to 2%; PSF + TOF2/17, 12% to 4%; Q.Clear, 10% to 6%), resulting in proportions comparable to original 7-mm data. Shorter acquisition time only increased proportions of discordant cases at < 90 s. CONCLUSIONS: ASP differences were mainly determined by reconstructed spatial resolution, and multicenter studies should aim at comparable FWHM (e.g., 7 mm; determined by in-plane filter width). This reduces discordant cases (high vs. low ASP) to an acceptable proportion for TOF and PSF + TOF of < 5% (Q.Clear: 10%). Data with better resolution (i.e., lower FWHM) could be retrospectively smoothed to the desired FWHM, resulting in a comparable number of discordant cases.
引用
- Rogasch JMM, Furth C, Bluemel S, et al. Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies. EJNMMI Res. 2020. PMID: 33140213. doi:10.1186/s13550-020-00725-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。